Researchers at Research Institute of the Diabetes Academy Mergen-theim Report Research in Type 1 Diabetes (Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time ...)

摘要

2021 MAY 05 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - Data detailed on type 1 diabetes have been presented. According to news reporting originating from Bad Mergentheim, Germany, by NewsRx correspondents, research stated, "Studies have shown beneficial effects of real-time continuous glucose monitoring (rtCGM) usage on clinical outcomes. The objective of this analysis was to identify which therapy adjustments were made by people with type 1 diabetes with impaired hypoglycemia awareness during rtCGM usage enabling reductions in the number of low glucose events observed in the HypoDE (Hypoglycemia in Deutschland) study." Funders for this research include Dexcom Inc..